As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

Whether the payer is a for-profit PBM in the U.S. or a single-payer government ... at “brick and mortar” pharmacies for other retail products instead of ordering the items from a convenient ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

The National Community Pharmacists Association (NPCA) is warning the feds that independent pharmacists are likely to face ...

The FTC study examines the practices of PBMs to ensure fair competition and transparency. The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty ...

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

Complex PBM money channels “make it hard to build ... and soon hopes to have a sort of “private reserve” of 70 to 80 products that it can make on short notice if they go into shortage ...

UnitedHealth Group (NYSE:UNH), a leading diversified healthcare company with a substantial market capitalization of $469.7 ...

The skyrocketing popularity of weight-loss drugs like Wegovy, one of a class of drugs called GLP-1s, is fast becoming a state ...

For decades, red light therapy has been an adjunct treatment for numerous ailments. But it may not work for all the medical conditions that supporters say it does.